Cours Isodiol International Inc Other OTC
Actions
CA46500L1013
Produits pharmaceutiques
CA 2018 | 19,14 M 17,39 M | CA 2019 | 22,25 M 20,22 M | Capitalisation | 49,96 M 45,4 M |
---|---|---|---|---|---|
Résultat net 2018 | -36 M -32,71 M | Résultat net 2019 | -126 M -114 M | VE / CA 2018 | 12,6 x |
Trésorerie nette 2018 | 15,55 M 14,13 M | Dette nette 2019 | 5,22 M 4,75 M | VE / CA 2019 | 2,48 x |
PER 2018 |
-4,94
x | PER 2019 |
-0,37
x | Employés | - |
Rendement 2018 * |
-
| Rendement 2019 |
-
| Flottant | 100% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/02/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Director/Board Member | - | 21/11/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+42,38% | 6,26 Md | |
-15,86% | 4,49 Md | |
+6,36% | 3,29 Md | |
-11,28% | 3,12 Md | |
-3,23% | 2,5 Md | |
+45,24% | 1,94 Md | |
-7,89% | 1,68 Md | |
-0,98% | 1,63 Md | |
-11,32% | 1,56 Md |